Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lipton

Showing results (961-970 of 1,173) with videos related to

Pageof 118
Sort By:
Headache|February 20, 2020
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and IIDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsAngel Garcia De La Garza, Carol A Derby, Qi Gao, et al.
Headache|October 4, 2025
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paperLawrence C Newman, Christine Lay, Richard B Lipton, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
Cephalalgia : an International Journal of Headache|February 26, 2009
Validity and reliability of the Migraine-Treatment Optimization QuestionnaireR B Lipton, K Kolodner, M E Bigal, et al.
Research in Sports Medicine (Print)|October 30, 2016
Validation and calibration of HeadCount, a self-report measure for quantifying heading exposure in soccer playersE Catenaccio, J Caccese, N Wakschlag, et al.
Health Science Reports|July 3, 2025
Daily Diary Smartphone Assessment of Subjective Cognitive Concerns in Motoric Cognitive Risk Syndrome: A Pilot StudyCaroline O Nester, Ángel García de la Garza, Jacqueline A Mogle, et al.
Journal of Alzheimer'S Disease : JAD|September 17, 2025
Sex-specific brain atrophy patterns associated with the motoric cognitive risk syndromeHelena M Blumen, Natalie Delpratt, Olivier Beauchet, et al.
Annals of Medicine|October 1, 1991
The interface between epidemiology and molecular biology in the search for the causes of insulin-dependent diabetes mellitusA L Drash, R B Lipton, J S Dorman, et al.
Pageof 118

Showing results (961-970 of 1,173) with videos related to

Sort By:
Pageof 118
Headache|February 20, 2020
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and IIDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsAngel Garcia De La Garza, Carol A Derby, Qi Gao, et al.
Headache|October 4, 2025
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paperLawrence C Newman, Christine Lay, Richard B Lipton, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
Cephalalgia : an International Journal of Headache|February 26, 2009
Validity and reliability of the Migraine-Treatment Optimization QuestionnaireR B Lipton, K Kolodner, M E Bigal, et al.
Research in Sports Medicine (Print)|October 30, 2016
Validation and calibration of HeadCount, a self-report measure for quantifying heading exposure in soccer playersE Catenaccio, J Caccese, N Wakschlag, et al.
Health Science Reports|July 3, 2025
Daily Diary Smartphone Assessment of Subjective Cognitive Concerns in Motoric Cognitive Risk Syndrome: A Pilot StudyCaroline O Nester, Ángel García de la Garza, Jacqueline A Mogle, et al.
Journal of Alzheimer'S Disease : JAD|September 17, 2025
Sex-specific brain atrophy patterns associated with the motoric cognitive risk syndromeHelena M Blumen, Natalie Delpratt, Olivier Beauchet, et al.
Annals of Medicine|October 1, 1991
The interface between epidemiology and molecular biology in the search for the causes of insulin-dependent diabetes mellitusA L Drash, R B Lipton, J S Dorman, et al.
Pageof 118